These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34139914)

  • 1. Targeting allosteric sites of human aromatase: a comprehensive
    Alhadrami HA; Sayed AM; Melebari SA; Khogeer AA; Abdulaal WH; Al-Fageeh MB; Algahtani M; Rateb ME
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1334-1345. PubMed ID: 34139914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design of allosteric modulators of the aromatase enzyme: An unprecedented therapeutic strategy to fight breast cancer.
    Spinello A; Martini S; Berti F; Pennati M; Pavlin M; Sgrignani J; Grazioso G; Colombo G; Zaffaroni N; Magistrato A
    Eur J Med Chem; 2019 Apr; 168():253-262. PubMed ID: 30822713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
    Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
    Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture.
    van Meeuwen JA; Korthagen N; de Jong PC; Piersma AH; van den Berg M
    Toxicol Appl Pharmacol; 2007 Jun; 221(3):372-83. PubMed ID: 17482226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated in silico-in vitro strategy for screening of some traditional Egyptian plants for human aromatase inhibitors.
    Dawood HM; Ibrahim RS; Shawky E; Hammoda HM; Metwally AM
    J Ethnopharmacol; 2018 Oct; 224():359-372. PubMed ID: 29909120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-digit nanomolar inhibitors lock the aromatase active site via a dualsteric targeting strategy.
    Caciolla J; Martini S; Spinello A; Belluti F; Bisi A; Zaffaroni N; Magistrato A; Gobbi S
    Eur J Med Chem; 2022 Dec; 244():114802. PubMed ID: 36240547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a multi-target compound for estrogen receptor-positive (ER
    Almeida CF; Teixeira N; Oliveira A; Augusto TV; Correia-da-Silva G; Ramos MJ; Fernandes PA; Amaral C
    Biochimie; 2021 Feb; 181():65-76. PubMed ID: 33278557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational approaches elucidate the allosteric mechanism of human aromatase inhibition: a novel possible route to Small-molecule regulation of CYP450s activities?
    Sgrignani J; Bon M; Colombo G; Magistrato A
    J Chem Inf Model; 2014 Oct; 54(10):2856-68. PubMed ID: 25178092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative activity, enzymatic inhibition and apoptosis-promoting effects of benzoxazole-based hybrids on human breast cancer cells.
    Omar AME; AboulWafa OM; Amr ME; El-Shoukrofy MS
    Bioorg Chem; 2021 Apr; 109():104752. PubMed ID: 33657444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limonoids and their anti-proliferative and anti-aromatase properties in human breast cancer cells.
    Kim J; Jayaprakasha GK; Patil BS
    Food Funct; 2013 Feb; 4(2):258-65. PubMed ID: 23117440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells.
    Martínez-Muñoz A; Prestegui-Martel B; Méndez-Luna D; Fragoso-Vázquez MJ; García-Sánchez JR; Bello M; Martínez-Archundia M; Chávez-Blanco A; Dueñas-González A; Mendoza-Lujambio I; Trujillo-Ferrara J; Correa-Basurto J
    Anticancer Agents Med Chem; 2018; 18(11):1629-1638. PubMed ID: 29745344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPMA copolymer-aminoglutethimide conjugates inhibit aromatase in MCF-7 cell lines.
    Greco F; Vicent MJ; Penning NA; Nicholson RI; Duncan R
    J Drug Target; 2005; 13(8-9):459-70. PubMed ID: 16332571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
    Kijima I; Itoh T; Chen S
    J Steroid Biochem Mol Biol; 2005 Dec; 97(4):360-8. PubMed ID: 16263272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines.
    Qamar S; Carrasquer CA; Cunningham SL; Cunningham AR
    Anticancer Res; 2011 Oct; 31(10):3247-52. PubMed ID: 21965732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective regulation of aromatase expression for drug discovery.
    Brueggemeier RW; Su B; Darby MV; Sugimoto Y
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):207-10. PubMed ID: 19931613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation.
    Ertas M; Sahin Z; Berk B; Yurttas L; Biltekin SN; Demirayak S
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700272. PubMed ID: 29522642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor effect of Shu-Gan-Liang-Xue decoction in breast cancer is related to the inhibition of aromatase and steroid sulfatase expression.
    Zhou N; Han SY; Zhou F; Li PP
    J Ethnopharmacol; 2014 Jul; 154(3):687-95. PubMed ID: 24809288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER.
    Zacarías-Lara OJ; Méndez-Luna D; Martínez-Ruíz G; García-Sanchéz JR; Fragoso-Vázquez MJ; Bello M; Becerra-Martínez E; García-Vázquez JB; Correa-Basurto J
    Anticancer Agents Med Chem; 2019; 19(6):760-771. PubMed ID: 30451119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on non-steroidal inhibitors of aromatase enzyme; 4-(aryl/heteroaryl)-2-(pyrimidin-2-yl)thiazole derivatives.
    Sahin Z; Ertas M; Berk B; Biltekin SN; Yurttas L; Demirayak S
    Bioorg Med Chem; 2018 May; 26(8):1986-1995. PubMed ID: 29525337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a novel orally active SERD AZD9496 against hormone dependent post-menopausal breast cancer depends on inhibition of cellular aromatase activity.
    Kazi A; Goloubeva O; Schech A; Yu S; Sabnis GJ
    J Steroid Biochem Mol Biol; 2020 Sep; 202():105697. PubMed ID: 32461092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.